Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eileen Francis

Reporter – US

Eileen Francis is a reporter for “The Tan Sheet,” where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of “The Rose Sheet,” IBI’s source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel.

Latest From Eileen Francis

Herbalife Raises 2021 Outlook As Largest Markets See Double-Digit Growth In Q1

Herbalife Nutrition's North American, Asia Pacific and EMEA regions recorded sales growth in excess of 20% each in the first quarter, as sales of energy, sports and fitness products soared 34%. The Los Angeles-based MLM company raised its full-year guidance accordingly, projecting net sales gains of 9% to 15%.

Wellness Sales & Earnings

Bausch CEO Papa Will Head Eye Health Biz Under Strategic Review

Bausch Health CEO Joseph Papa will move over to head separate Bausch + Lomb pure-play eye health business and is preparing a team for either a spin-off or initial public offering of the unit in the third quarter, the executive said during a first quarter earning call 4 May. Papa said a sale of the division, which includes consumer health eye drops and dietary supplements, is also possible.

Health Business Strategies

Colgate Weathers US ‘Perfect Storm,' Grows 6% Worldwide In Q1

Colgate-Palmolive's North American business slipped 0.5% on category deceleration associated with stockpiling and costs from raw materials and inflation, the New York-based firm reported on 30 April. Premium innovations, advertising and price increases should improve the business in the back half of the year.

Health Commercial

COVID-19 Stress Drives Anxiety-Reducing Supplement Sales Up 79% In US Since 2018

Sales for anxiety/stress relief dietary supplements in 2020 grew 79% from 2018, eclipsing growth of 22% for general herbal supplements during the same comparison period. Stress-relief supplements including St. John’s wart, ashwagandha and cannabinoids continue to grow in popularity.

Dietary Supplements Coronavirus COVID-19

Unilever Gets Portfolio In Order While Riding Prestige Beauty, Functional Nutrition Growth

Unilever’s prestige beauty business, bulked up by acquisitions over the past five years, achieved 21% underlying sales growth in the FY 2021 first quarter. The firm has formed a new business unit, Elida Beauty, to house a number of smaller, non-core beauty and personal-care brands accounting for around 600m in revenues following talk of possible divestitures.

Beauty Wellness

GSK Sees Other Side Of Consumer Health Stockpiling Coin, Looks Ahead To Business Split

GSK reports pandemic-related stockpiling in 2020 combined with a weak cold and flu season in Q1 drove its consumer health sales down 9%, with the sharpest downturn in respiratory products sales. The firm expects in the second half of the year to see “more normal consumer trends.”

Commercial OTC Drugs
See All
UsernamePublicRestriction

Register